1. Home
  2. AKBA vs HRTG Comparison

AKBA vs HRTG Comparison

Compare AKBA & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKBA
  • HRTG
  • Stock Information
  • Founded
  • AKBA 2007
  • HRTG 2012
  • Country
  • AKBA United States
  • HRTG United States
  • Employees
  • AKBA N/A
  • HRTG N/A
  • Industry
  • AKBA Biotechnology: Pharmaceutical Preparations
  • HRTG Property-Casualty Insurers
  • Sector
  • AKBA Health Care
  • HRTG Finance
  • Exchange
  • AKBA Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • AKBA 336.2M
  • HRTG 341.5M
  • IPO Year
  • AKBA 2014
  • HRTG 2014
  • Fundamental
  • Price
  • AKBA $1.93
  • HRTG $15.54
  • Analyst Decision
  • AKBA Strong Buy
  • HRTG Buy
  • Analyst Count
  • AKBA 3
  • HRTG 3
  • Target Price
  • AKBA $6.50
  • HRTG $12.50
  • AVG Volume (30 Days)
  • AKBA 6.1M
  • HRTG 245.8K
  • Earning Date
  • AKBA 05-08-2025
  • HRTG 03-11-2025
  • Dividend Yield
  • AKBA N/A
  • HRTG N/A
  • EPS Growth
  • AKBA N/A
  • HRTG 16.20
  • EPS
  • AKBA N/A
  • HRTG 2.01
  • Revenue
  • AKBA $160,180,000.00
  • HRTG $816,985,000.00
  • Revenue This Year
  • AKBA $23.40
  • HRTG $9.30
  • Revenue Next Year
  • AKBA $58.44
  • HRTG $6.12
  • P/E Ratio
  • AKBA N/A
  • HRTG $7.65
  • Revenue Growth
  • AKBA N/A
  • HRTG 11.08
  • 52 Week Low
  • AKBA $0.80
  • HRTG $6.14
  • 52 Week High
  • AKBA $2.89
  • HRTG $16.90
  • Technical
  • Relative Strength Index (RSI)
  • AKBA 46.74
  • HRTG 72.49
  • Support Level
  • AKBA $1.83
  • HRTG $13.62
  • Resistance Level
  • AKBA $1.99
  • HRTG $14.28
  • Average True Range (ATR)
  • AKBA 0.19
  • HRTG 0.77
  • MACD
  • AKBA -0.03
  • HRTG 0.18
  • Stochastic Oscillator
  • AKBA 15.42
  • HRTG 98.82

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally.

Share on Social Networks: